Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 85.39M | 71.14M | 83.34M | 84.07M | 81.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.39M | 71.14M | 83.34M | 84.07M | 81.80M |
| Cost of Revenue | 59.71M | 49.65M | 50.75M | 48.56M | 47.37M |
| Gross Profit | 25.68M | 21.49M | 32.58M | 35.51M | 34.44M |
| SG&A Expenses | 42.12M | 37.31M | 50.70M | 34.98M | 38.68M |
| Depreciation & Amortization | 2.60M | 2.03M | 2.03M | 2.03M | 1.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 118.99M | 103.16M | 117.65M | 99.42M | 101.52M |
| Operating Income | -33.60M | -32.02M | -34.31M | -15.35M | -19.71M |
| Income Before Tax | -29.69M | -25.98M | -29.27M | -7.51M | -21.52M |
| Income Tax Expenses | 29.00K | -704.00K | -5.62M | -683.00K | -2.26M |
| Earnings from Continuing Operations | -29.72M | -25.27M | -23.65M | -6.83M | -19.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 189.00K | 448.00K | 232.00K | 218.00K | 299.00K |
| Net Income | -29.53M | -24.83M | -23.42M | -6.61M | -18.96M |
| EBIT | -33.60M | -32.02M | -34.31M | -15.35M | -19.71M |
| EBITDA | -25.93M | -26.02M | -28.20M | -9.31M | -13.66M |
| EPS Basic | -1.05 | -0.80 | -0.76 | -0.21 | -0.62 |
| Normalized Basic EPS | -0.60 | -0.46 | -0.54 | -0.15 | -0.23 |
| EPS Diluted | -1.05 | -0.80 | -0.76 | -0.21 | -0.62 |
| Normalized Diluted EPS | -0.60 | -0.46 | -0.54 | -0.15 | -0.23 |
| Average Basic Shares Outstanding | 28.01M | 30.88M | 30.98M | 30.75M | 30.54M |
| Average Diluted Shares Outstanding | 28.01M | 30.88M | 30.98M | 30.75M | 30.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |